ATHIRA PHARMA INC's ticker is ATHA and the CUSIP is 04746L104. A total of 106 filers reported holding ATHIRA PHARMA INC in Q2 2022. The put-call ratio across all filers is 0.31 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $125,384 | -62.8% | 62,071 | -45.6% | 0.00% | – |
| Q2 2023 | $336,820 | -58.1% | 114,176 | -64.5% | 0.00% | – |
| Q1 2023 | $803,445 | +62.6% | 321,377 | +106.2% | 0.00% | – |
| Q4 2022 | $494,144 | -15.7% | 155,881 | -21.0% | 0.00% | – |
| Q3 2022 | $586,000 | +190.1% | 197,298 | +198.4% | 0.00% | – |
| Q2 2022 | $202,000 | -78.3% | 66,122 | -3.9% | 0.00% | – |
| Q1 2022 | $929,000 | -23.3% | 68,792 | -26.0% | 0.00% | – |
| Q4 2021 | $1,211,000 | -27.8% | 92,919 | -48.0% | 0.00% | – |
| Q3 2021 | $1,677,000 | -40.8% | 178,773 | -35.4% | 0.00% | – |
| Q2 2021 | $2,831,000 | +585.5% | 276,538 | +1132.1% | 0.00% | – |
| Q1 2021 | $413,000 | -30.0% | 22,445 | +30.4% | 0.00% | – |
| Q4 2020 | $590,000 | +2581.8% | 17,215 | +1334.6% | 0.00% | – |
| Q3 2020 | $22,000 | – | 1,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 1,691,623 | $57,938,000 | 8.52% |
| ACUTA CAPITAL PARTNERS, LLC | 393,000 | $13,460,000 | 3.66% |
| Logos Global Management LP | 947,873 | $32,465,000 | 2.78% |
| RTW INVESTMENTS, LP | 2,685,779 | $88,899,000 | 1.49% |
| Avidity Partners Management LP | 1,043,873 | $35,753,000 | 1.16% |
| Perceptive Advisors | 3,114,805 | $106,682,000 | 1.14% |
| Sofinnova Investments, Inc. | 509,168 | $17,439,000 | 1.04% |
| HighVista Strategies LLC | 32,062 | $1,098,000 | 0.70% |
| Rock Springs Capital Management LP | 860,902 | $29,486,000 | 0.62% |
| PFM Health Sciences, LP | 470,227 | $16,105,000 | 0.57% |